Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align’s Common Stock

TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of … [Read more…]

Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant

Topline results expected H2 2025 REDWOOD CITY, Calif.–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last patient, last visit in its ongoing Phase 2 clinical trial (NCT05561751) evaluating the safety and efficacy of GPC-100 (burixafor) in combination with propranolol and G-CSF in multiple … [Read more…]

Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents

CINCINNATI–(BUSINESS WIRE)–Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has … [Read more…]

Turiya Anesthesia of Citrus Valley to Commence Anesthesiology Services at Emanate Health Foothill Presbyterian Hospital

COVINA, Calif.–(BUSINESS WIRE)–Turiya Anesthesia, a leading provider of high-quality anesthesia services in Southern California, is thrilled to announce the expansion of its partnership with Emanate Health to now include Foothill Presbyterian Hospital located at 250 South Grand Ave, Glendora, California. Building on the success of Turiya Anesthesia’s existing Anesthesiology services at Emanate Health Inter-Community Hospital, … [Read more…]

Natera Highlights Latest Prospera™ Data at WTC 2025; 16 Abstracts Including Five Oral Presentations

High-impact datasets across heart, kidney and lung at WTC follows two major publications in the American Journal of Transplantation in the last three months AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will present several new datasets at the 2025 World Transplant Congress (WTC), … [Read more…]

Trividia Health UK Announces Launch of TRUEplus 5-Bevel Pen Needles in UK

Providing Pen Needles Especially Designed for Comfort at a Lower Cost LONDON & FT. LAUDERDALE, Fla.–(BUSINESS WIRE)–#diabetes–Trividia Health UK Limited, announced today that the TRUEplus 5-Bevel Pen Needles are now available in the United Kingdom. This new 5-bevel insulin pen needle line gives healthcare providers the ability to provide a variety of different needle gauges … [Read more…]

STAAR Surgical to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025

LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results for the second quarter ended June 27, 2025, on Wednesday, August 6, 2025 after the market close. The Company will … [Read more…]

Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.

New Wound Healing Breakthrough With Ovine Nano-Collagen QBx™ Integration LAS VEGAS–(BUSINESS WIRE)–Regenerex Pharma, Inc. (OTC: RGPX), a leading innovator in advanced wound closure systems for chronic wounds, today announced the development of new product formulations designed to accelerate deep tissue regeneration through enhanced scaffolding facilitation and cell proliferation. Building on its patented QBx™ technology, Regenerex … [Read more…]

Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors

PASADENA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced the appointment of Raymond J. Deshaies, Ph.D., to its board of directors. Dr. Deshaies is a pioneering biochemist and cell biologist with more than 25 years of experience in biotechnology and drug development. … [Read more…]

Cold Chain Market for Pharmaceuticals Forecast Report 2025-2035: Over 90 Patents Filed in Thriving Cold Chain Pharmaceutical Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cold Chain Market for Pharmaceuticals – Industry Trends and Global Forecasts to 2035: Distribution by Type of Primary Packaging, Type of Secondary Packaging, Type of Usability and Key Geographical Regions” report has been added to ResearchAndMarkets.com’s offering. The global cold chain market for pharmaceuticals is estimated to grow from USD 6.38 billion in … [Read more…]